How much funding has NeuroPace raised?

NeuroPace has raised $198.1M in total funding, most recently a Extension Round.

Who are NeuroPace's investors?

NeuroPace's investors include KCK Group, OrbiMed, Accelmed Partners, Revelation Partners, Soleus Capital.

Where is NeuroPace headquartered?

NeuroPace is headquartered in Mountain View, California, United States.

What industry is NeuroPace in?

NeuroPace operates in Hardware, Healthcare, Medical Devices.

How many employees does NeuroPace have?

NeuroPace has 201-500 employees.

NeuroPace

IPO

Home Page

Public · Mountain View, United States · Founded 1997 · $198.1M raised

Hardware

Healthcare

Medical Devices

Headquarters: Mountain View, California
Employees: 201–500
Founded: 1997
Business Model: B2B
Website: neuropace.com

Total Funding: $198.1M
Last Round: $67.0M Extension RoundAug 2020
Rounds: 4
Type: Public

About

NeuroPace is a commercial-stage medical device company focused on transforming the lives of people with epilepsy. Its RNS System is the first FDA-approved brain-responsive neurostimulation platform that delivers personalized, real-time treatment at the seizure source for drug-resistant focal epilepsy.

Summary

NeuroPace is a Hardware company based in Mountain View, United States, founded in 1997. It has raised $198.1M in total across 4 rounds, most recently a $67.0M Extension Round round in Aug 2020. Investors include KCK Group, OrbiMed and Accelmed Partners.

LinkedIn X (Twitter)